$11.47
Enanta Pharmaceuticals is a biotechnology business based in the US. Enanta Pharmaceuticals shares (ENTA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $12.10 – an increase of 12.98% over the previous week. Enanta Pharmaceuticals employs 145 staff and has a trailing 12-month revenue of around $72 million.
Our top picks for where to buy Enanta Pharmaceuticals stock
- Earn 4.5% interest on uninvested cash with Gold
- Get up to $50,000 in instant deposits with Gold
- Easy, user-friendly trading
- Unlimited bonus amounts Oct 16-27
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Enanta Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ENTA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Enanta Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Enanta Pharmaceuticals stock price (NASDAQ: ENTA)
Use our graph to track the performance of ENTA stocks over time.Enanta Pharmaceuticals shares at a glance
Latest market close | $12.10 |
---|---|
52-week range | $8.08 - $17.80 |
50-day moving average | $11.89 |
200-day moving average | $13.12 |
Wall St. target price | $21.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-5.58 |
Is it a good time to buy Enanta Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Enanta Pharmaceuticals price performance over time
Historical closes compared with the close of $11.67 from 2024-10-15
1 week (2024-10-10) | 9.78% |
---|---|
1 month (2024-09-17) | 0.17% |
3 months (2024-07-17) | -26.23% |
6 months (2024-04-17) | -16.64% |
1 year (2023-10-17) | 17.64% |
---|---|
2 years (2022-10-17) | -75.90% |
3 years (2021-10-15) | 71.47 |
5 years (2019-10-17) | 60.84 |
Enanta Pharmaceuticals financials
Revenue TTM | $72 million |
---|---|
Gross profit TTM | $86.2 million |
Return on assets TTM | -17.18% |
Return on equity TTM | -59.64% |
Profit margin | -160.27% |
Book value | $7.03 |
Market Capitalization | $239.6 million |
TTM: trailing 12 months
Enanta Pharmaceuticals share dividends
We're not expecting Enanta Pharmaceuticals to pay a dividend over the next 12 months.
Enanta Pharmaceuticals share price volatility
Over the last 12 months, Enanta Pharmaceuticals's shares have ranged in value from as little as $8.08 up to $17.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Enanta Pharmaceuticals's is 0.584. This would suggest that Enanta Pharmaceuticals's shares are less volatile than average (for this exchange).
Enanta Pharmaceuticals overview
Enanta Pharmaceuticals, Inc. , a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. The company has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. Enanta Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Watertown, Massachusetts. .
Frequently asked questions
nullWhat percentage of Enanta Pharmaceuticals is owned by insiders or institutions?
Currently 6.09% of Enanta Pharmaceuticals shares are held by insiders and 104.527% by institutions. How many people work for Enanta Pharmaceuticals?
Latest data suggests 145 work at Enanta Pharmaceuticals. When does the fiscal year end for Enanta Pharmaceuticals?
Enanta Pharmaceuticals's fiscal year ends in September. Where is Enanta Pharmaceuticals based?
Enanta Pharmaceuticals's address is: 500 Arsenal Street, Watertown, MA, United States, 02472 What is Enanta Pharmaceuticals's ISIN number?
Enanta Pharmaceuticals's international securities identification number is: US29251M1062 What is Enanta Pharmaceuticals's CUSIP number?
Enanta Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 29251M106
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
eToro review 2024: Commission-free social trading and investing
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question